|
US4190659A
(en)
*
|
1973-08-27 |
1980-02-26 |
Sandoz, Inc. |
Pharmaceutical preparation and use of 4-hydroxy-2-quinolinone-3-carboxylic acid esters
|
|
US4187309A
(en)
*
|
1977-06-20 |
1980-02-05 |
Sandoz, Inc. |
4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
|
|
US4281131A
(en)
|
1977-06-20 |
1981-07-28 |
Sandoz, Inc. |
4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
|
|
US4273930A
(en)
*
|
1977-06-20 |
1981-06-16 |
Sandoz, Inc. |
4-Hydroxy-2-quinolinone-3-carboxylic acid esters
|
|
US4221797A
(en)
*
|
1978-08-14 |
1980-09-09 |
Sandoz, Inc. |
Dihydroquinoline-one derivatives
|
|
FR2443467A1
(fr)
*
|
1978-12-08 |
1980-07-04 |
Roussel Uclaf |
Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
|
|
FR2482596A1
(fr)
*
|
1980-05-19 |
1981-11-20 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur procede de preparation et leur application comme medicament
|
|
US4266050A
(en)
*
|
1980-07-02 |
1981-05-05 |
American Home Products Corporation |
1,2-Dihydro-4-hydroxy-2-imino-N-substituted-3-quinolinecarboxamide derivatives
|
|
IE52670B1
(en)
*
|
1981-03-03 |
1988-01-20 |
Leo Ab |
Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
|
|
HU190796B
(en)
*
|
1981-06-12 |
1986-11-28 |
Roussel Uclaf,Fr |
Process for producing n-dihydrothiazolyl-3-quinoline-carboxamide derivatives
|
|
FR2507602A1
(fr)
*
|
1981-06-12 |
1982-12-17 |
Roussel Uclaf |
Nouveau derive dihydrothiazole de la quinoleine, ses sels, procede de preparation, application a titre de medicaments et compositions les renfermant
|
|
FR2523130A1
(fr)
*
|
1982-03-15 |
1983-09-16 |
Roussel Uclaf |
Nouveaux derives de la n-dihydrothiazolyl-3-quinoleine carboxamide, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
|
|
FR2509728A1
(fr)
*
|
1981-07-17 |
1983-01-21 |
Roussel Uclaf |
Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
|
|
FR2537139B2
(fr)
*
|
1982-03-15 |
1985-09-20 |
Roussel Uclaf |
Nouveau derive de la n-dihydrothiazolyl 3-quinoleine carboxamide, procede de preparation, application a titre de medicament et compositions le renfermant
|
|
FR2551437B2
(fr)
*
|
1982-06-03 |
1985-10-25 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-oh 3-quinoleine carboxylique substitues en 2, nouveau procede de preparation, leur application comme medicament et les compositions les renfermant et produits necessaires a leur preparation
|
|
FR2530633A1
(fr)
*
|
1982-06-03 |
1984-01-27 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, et les compositions les renfermant
|
|
FR2532939A1
(fr)
*
|
1982-09-13 |
1984-03-16 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, les compositions les renfermant et les nouveaux intermediaires obtenus
|
|
FR2537140B1
(fr)
*
|
1982-12-07 |
1986-07-18 |
Roussel Uclaf |
Nouveaux derives de la 4-hydroxy-3-quinoleine carboxamide, leur sels, procede de preparation, application a titre de medicaments, et compositions les renfermant
|
|
SE452170B
(sv)
*
|
1983-10-03 |
1987-11-16 |
Boliden Ab |
Forfarande for utvinning av metall ur koppar och/eller edelmetall innehallande material som innehaller antimon och vismut
|
|
FR2566405B1
(fr)
*
|
1984-06-25 |
1986-09-26 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus
|
|
US4602014A
(en)
*
|
1984-07-09 |
1986-07-22 |
Ciba-Geigy Corporation |
Ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives as benzodiazepine receptor modulators
|
|
JPH0358559A
(ja)
*
|
1989-07-26 |
1991-03-13 |
Sekisui Chem Co Ltd |
電話システム
|
|
US5175151A
(en)
*
|
1990-09-07 |
1992-12-29 |
Schering Corporation |
Antiviral compounds and antihypertensive compounds
|
|
CA2091172C
(en)
*
|
1990-09-07 |
1997-05-20 |
Adriano Afonso |
Antiviral compounds and antihypertensive compounds
|
|
US5179093A
(en)
*
|
1991-05-10 |
1993-01-12 |
Schering Corporation |
Quinoline-diones
|
|
DE4138820A1
(de)
*
|
1991-11-26 |
1993-05-27 |
Basf Ag |
Chinolin-3-carbonsaeureamide, deren herstellung und verwendung
|
|
SE9201076L
(sv)
*
|
1992-04-06 |
1993-10-07 |
Shimon Slavin |
Användningen av gamla läkemedel för behandling av diabetes
|
|
SE9400810D0
(sv)
*
|
1994-03-10 |
1994-03-10 |
Pharmacia Ab |
New use of Quinoline-3-carboxamide compounds
|
|
SE9400809D0
(sv)
*
|
1994-03-10 |
1994-03-10 |
Pharmacia Ab |
New use of quinoline-3-carboxamide compounds
|
|
TWI328009B
(en)
*
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
|
SE0400235D0
(sv)
*
|
2004-02-06 |
2004-02-06 |
Active Biotech Ab |
New composition containing quinoline compounds
|
|
US8314124B2
(en)
|
2004-02-06 |
2012-11-20 |
Active Biotech Ab |
Crystalline salts of quinoline compounds and methods for preparing them
|
|
US8354427B2
(en)
*
|
2004-06-24 |
2013-01-15 |
Vertex Pharmaceutical Incorporated |
Modulators of ATP-binding cassette transporters
|
|
RU2528046C2
(ru)
*
|
2004-06-24 |
2014-09-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Модуляторы транспортеров атф-связывающей кассеты
|
|
PL2489659T3
(pl)
|
2004-06-24 |
2018-06-29 |
Vertex Pharma |
Modulatory transporterów posiadających kasetę wiążącą atp
|
|
WO2006087830A1
(ja)
*
|
2005-02-18 |
2006-08-24 |
Kanebo, Ltd. |
帯状織物構造体およびその製法
|
|
SI1937642T1
(sl)
*
|
2005-10-19 |
2015-01-30 |
Teva Pharmaceutical Industries Ltd. |
Kristali natrijevega lakvinimoda in postopek za njihovo pripravo
|
|
WO2007075901A2
(en)
*
|
2005-12-24 |
2007-07-05 |
Vertex Pharmaceuticals Incorporated |
Quinolin- 4 - one derivatives as modulators of abc transporters
|
|
JP5409010B2
(ja)
|
2005-12-28 |
2014-02-05 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
N−[2,4−ビス(1,1−ジメチルエチル)−5−ヒドロキシフェニル]−1,4−ジヒドロ−4−オキソキノリン−3−カルボキサミドの固体形態
|
|
AU2007258366B2
(en)
|
2006-06-12 |
2012-10-25 |
Active Biotech, Ab |
Stable laquinimod preparations
|
|
US20080221161A1
(en)
*
|
2007-02-09 |
2008-09-11 |
Kalypsys, Inc. |
Heterocyclic modulators of tgr5 for treatment of disease
|
|
PL2234485T3
(pl)
*
|
2007-12-20 |
2014-06-30 |
Teva Pharma |
Stabilne preparaty lakwinimodu
|
|
US12458635B2
(en)
|
2008-08-13 |
2025-11-04 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition and administrations thereof
|
|
US20100074949A1
(en)
|
2008-08-13 |
2010-03-25 |
William Rowe |
Pharmaceutical composition and administration thereof
|
|
UA104005C2
(ru)
*
|
2008-09-03 |
2013-12-25 |
Тева Фармасьютикл Индастриз, Лтд. |
2-оксо-1,2-дигидрохинолиновые модуляторы иммунной функции
|
|
US8476442B2
(en)
|
2009-03-20 |
2013-07-02 |
Vertex Pharmaceutical Incorporated |
Process for making modulators of cystic fibrosis transmembrane conductance regulator
|
|
PL2458992T3
(pl)
*
|
2009-07-30 |
2016-07-29 |
Teva Pharma |
Leczenie choroby Leśniowskiego-Crohna z użyciem lakwinimodu
|
|
EP2467372B1
(en)
*
|
2009-08-10 |
2016-05-18 |
Teva Pharmaceutical Industries Ltd. |
Treatment of bdnf-related disorders using laquinimod
|
|
ES2558556T3
(es)
*
|
2010-03-03 |
2016-02-05 |
Teva Pharmaceutical Industries Ltd. |
Tratamiento de nefritis lúpica usando laquinimod
|
|
ES2601819T3
(es)
*
|
2010-03-03 |
2017-02-16 |
Teva Pharmaceutical Industries Ltd. |
Tratamiento de la artritis lúpica usando laquinimod
|
|
DK2542079T3
(da)
*
|
2010-03-03 |
2014-08-25 |
Teva Pharma |
Behandling af reumatoid artritis med en kombination af laquinimod og methotrexat
|
|
CN102267984B
(zh)
*
|
2010-06-04 |
2014-07-30 |
中国人民解放军军事医学科学院毒物药物研究所 |
4-羟基喹啉-3-酰胺衍生物及其制备方法和用途
|
|
EP2627638B1
(en)
|
2010-10-14 |
2017-07-12 |
Immunahr AB |
1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators.
|
|
US8802700B2
(en)
|
2010-12-10 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
|
EP2537517A1
(en)
*
|
2011-06-22 |
2012-12-26 |
Active Biotech AB |
Deuterium-enriched 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-[(4-trifluoro-methyl)phenyl]-1,2-dihydroquinoline-3-carboxamide
|
|
JP2014530821A
(ja)
|
2011-10-12 |
2014-11-20 |
テバ ファーマシューティカル インダストリーズ リミティド |
ラキニモドおよびフィンゴリモドを組み合わせた多発性硬化症の治療
|
|
CA2862865A1
(en)
|
2012-02-03 |
2013-08-08 |
Teva Pharmaceutical Industries Ltd. |
Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf.alpha. therapy
|
|
CA2865519C
(en)
|
2012-02-27 |
2018-01-02 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions comprising a solid dispersion of n-[2,4-bis(1,1-dimethylethyl0-5-hydroxyphenyl-1]-1,4-dihydro-4-oxoquinolone-3-carboxamide for treating cystic fibrosis
|
|
TW201400117A
(zh)
|
2012-06-05 |
2014-01-01 |
Teva Pharma |
使用拉喹莫德治療眼發炎疾病
|
|
EP2916915A4
(en)
|
2012-11-07 |
2016-06-22 |
Teva Pharma |
LAQUINIMOD AMINE SALTS
|
|
NZ710111A
(en)
|
2013-01-31 |
2020-08-28 |
Vertex Pharma |
Quinoline and quinoxaline amides as modulators of sodium channels
|
|
MX2015011627A
(es)
|
2013-03-14 |
2016-05-16 |
Teva Pharma |
Cristales de laquinimod sodico y proceso mejorado para la elaboracion de los mismos.
|
|
WO2015168103A1
(en)
|
2014-04-29 |
2015-11-05 |
Teva Pharmaceutical Industries Ltd. |
Laquinimod for the treatment of relapsing-remitting multiple sclerosis (rrms) patients with a high disability status
|
|
KR20170063954A
(ko)
|
2014-10-07 |
2017-06-08 |
버텍스 파마슈티칼스 인코포레이티드 |
낭성 섬유증 막횡단 전도도 조절자의 조정제의 공-결정
|